Cancer Chemotherapy and Pharmacology
Springer Science+Business Media
About the journal
Cancer Chemotherapy and Pharmacology is a journal published by Springer Science+Business Media in Germany. It is listed in MEDLINE according to the sources read. Declared publication charge: 3,990 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer Science+Business Media
- ISSN
- 0344-5704 · 1432-0843
- Country
- Germany
- Access
- Not open access / not declared
- Declared publication charge
- 3,990 EUR
- Declared peer-review model
- peer_review
- Official website
- http://www.springer.com/medicine/oncology/journal/280
Index listings
- MEDLINE · 1978-01-01
- Indexing
- MEDLINE
- APC
- 3,990 EUR
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 115 days received→accepted — computed from PubMed (n=96)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
9861
Last recorded publication year
2026
h-index
154
i10-index
6538
From OpenAlex open data (CC0).
Editorial & policy6
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 96%
- ORCID iDs in current deposits
- 49%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- Cancer chemotherapy and pharmacology (Print
- Source type
- journal
- NLM unique ID (PubMed)
- 7806519
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Cancer therapeutics and mechanisms
- Cancer therapeutics and mechanisms
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Lung Cancer Research Studies
Show all subjects (50)
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Chemotherapy-induced organ toxicity mitigation
- Chemotherapy-induced organ toxicity mitigation
- Drug Transport and Resistance Mechanisms
- Drug Transport and Resistance Mechanisms
- Chemotherapy-induced cardiotoxicity and mitigation
- Chemotherapy-induced cardiotoxicity and mitigation
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Gastric Cancer Management and Outcomes
- Gastric Cancer Management and Outcomes
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Neutropenia and Cancer Infections
- Neutropenia and Cancer Infections
- Hepatocellular Carcinoma Treatment and Prognosis
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Pharmacogenetics and Drug Metabolism
- Pharmacogenetics and Drug Metabolism
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Nanoparticle-Based Drug Delivery
- Nanoparticle-Based Drug Delivery
- Neuroendocrine Tumor Research Advances
- Neuroendocrine Tumor Research Advances
- Metal complexes synthesis and properties
- Metal complexes synthesis and properties
- Estrogen and related hormone effects
- Estrogen and related hormone effects
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- PI3K/AKT/mTOR signaling in cancer
- PI3K/AKT/mTOR signaling in cancer
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ